Cilostazol - 0615-7747-39 - (Cilostazol)

Alphabetical Index


Drug Information of Cilostazol

Product NDC: 0615-7747
Proprietary Name: Cilostazol
Non Proprietary Name: Cilostazol
Active Ingredient(s): 100    mg/1 & nbsp;   Cilostazol
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Cilostazol

Product NDC: 0615-7747
Labeler Name: NCS HealthCare of KY, Inc dba Vangard Labs
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA077027
Marketing Category: ANDA
Start Marketing Date: 20121115

Package Information of Cilostazol

Package NDC: 0615-7747-39
Package Description: 30 TABLET in 1 BLISTER PACK (0615-7747-39)

NDC Information of Cilostazol

NDC Code 0615-7747-39
Proprietary Name Cilostazol
Package Description 30 TABLET in 1 BLISTER PACK (0615-7747-39)
Product NDC 0615-7747
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Cilostazol
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20121115
Marketing Category Name ANDA
Labeler Name NCS HealthCare of KY, Inc dba Vangard Labs
Substance Name CILOSTAZOL
Strength Number 100
Strength Unit mg/1
Pharmaceutical Classes Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA]

Complete Information of Cilostazol


General Information